AAAAAA

   
Results: 1-15 |
Results: 15
Bone scan had no role in the staging of 765 consecutive operable T1-2N0-1 breast cancer patients without skeletal symptoms
Authors: Curigliano, G Ferretti, G Colleoni, M Marrocco, E Peruzzotti, G De Cicco, C Paganelli, G Goldhirsch, A
Citation: G. Curigliano et al., Bone scan had no role in the staging of 765 consecutive operable T1-2N0-1 breast cancer patients without skeletal symptoms, ANN ONCOL, 12(5), 2001, pp. 724-725
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer
Authors: Fogli, S Danesi, R Braud, FD Pas, TD Curigliano, G Giovannetti, E Del Tacca, M
Citation: S. Fogli et al., Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer, ANN ONCOL, 12(11), 2001, pp. 1553-1559
Gemcitabine-induced systemic capillary leak syndrome
Authors: De Pas, T Curigliano, G Franceschelli, L Catania, C Spaggiari, L de Braud, F
Citation: T. De Pas et al., Gemcitabine-induced systemic capillary leak syndrome, ANN ONCOL, 12(11), 2001, pp. 1651-1652
Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradientgel electrophoresis urinalysis
Authors: Curigliano, G Ferretti, G Flamini, G Goldhirsch, A de Braud, F Calabro, MG Mandaly, M Nole, F De Pas, T D'Addessi, A Cittadini, A
Citation: G. Curigliano et al., Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradientgel electrophoresis urinalysis, ANTICANC R, 21(4B), 2001, pp. 3015-3020
Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients
Authors: Mandala, M Moro, C Ferretti, G Calabro, MG Nole, F Rocca, A Munzone, E Castro, A Curigliano, G
Citation: M. Mandala et al., Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients, ANTICANC R, 21(1B), 2001, pp. 585-588
Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine
Authors: De Pas, T de Braud, F Mandala, M Curigliano, G Catania, C Ferretti, G Sozzi, P Solli, P Goldhirsch, A
Citation: T. De Pas et al., Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine, LUNG CANC, 31(2-3), 2001, pp. 267-270
Progress report on the palliative therapy of 100 patients with neoplastic effusions by intracavitary low-dose interleukin-2
Authors: Lissoni, P Mandala, M Curigliano, G Ferretti, G Moro, C Ardizzoia, A Malugani, F Tancini, G Tisi, E Arrigoni, C Barni, S
Citation: P. Lissoni et al., Progress report on the palliative therapy of 100 patients with neoplastic effusions by intracavitary low-dose interleukin-2, ONCOL-BASEL, 60(4), 2001, pp. 308-312
Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer
Authors: Ferretti, G Curigliano, G Pastorino, U Cittadini, A Flamini, G Calabro, MG De Pas, T Orlando, L Mandala, M Colleoni, M Spaggiari, L Granone, PL Pagliari, G de Braud, F Fazio, N Goldhirsch, A
Citation: G. Ferretti et al., Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer, CLIN CANC R, 6(6), 2000, pp. 2393-2400
Ifosfamide in the elderly: clinical considerations for a better drug management
Authors: De Pas, T Curigliano, G Catania, C Comandone, A de Braud, F
Citation: T. De Pas et al., Ifosfamide in the elderly: clinical considerations for a better drug management, CR R ONC H, 33(2), 2000, pp. 129-135
Response to primary chemotherapy in breast cancer patients with tumors notexpressing estrogen and progesterone receptors
Authors: Colleoni, M Minchella, I Mazzarol, G Nole, F Peruzzotti, G Rocca, A Viale, G Orlando, L Ferretti, G Curigliano, G Veronesi, P Intra, M Goldhirsch, A
Citation: M. Colleoni et al., Response to primary chemotherapy in breast cancer patients with tumors notexpressing estrogen and progesterone receptors, ANN ONCOL, 11(8), 2000, pp. 1057-1059
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer
Authors: De Pas, T de Braud, F Danesi, R Sessa, C Catania, C Curigliano, G Fogli, S del Tacca, M Zampino, G Sbanotto, A Rocca, A Cinieri, S Marrocco, E Milani, A Goldhirsch, A
Citation: T. De Pas et al., Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer, ANN ONCOL, 11(7), 2000, pp. 821-827
Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?
Authors: Orlando, L Colleoni, M Nole, F Biffi, R Rocca, A Curigliano, G Ferretti, G Peruzzotti, G de Braud, F Masci, G Goldhirsch, A
Citation: L. Orlando et al., Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?, ANN ONCOL, 11(1), 2000, pp. 117-118
Acute vulvar vestibulitis occurring during chemotherapy with cryptophycin analogue LY355703
Authors: De Pas, TM Mandala, M Curigliano, G Peccatori, F
Citation: Tm. De Pas et al., Acute vulvar vestibulitis occurring during chemotherapy with cryptophycin analogue LY355703, OBSTET GYN, 95(6), 2000, pp. 1030-1030
Evaluation of polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral cells by an immunohistochemical assay
Authors: Romano, G Sgambato, A Boninsegna, A Flamini, G Curigliano, G Yang, Q La Gioia, V Signorelli, C Ferro, A Capelli, G Santella, RM Cittadini, A
Citation: G. Romano et al., Evaluation of polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral cells by an immunohistochemical assay, CANC EPID B, 8(1), 1999, pp. 91-96
Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma
Authors: Romano, G Garagnani, L Boninsegna, A Ferrari, P Flamini, G De Gaetani, C Sgambato, A Giovanni, F Curigliano, G Ferretti, G Cittadini, A Trentini, G
Citation: G. Romano et al., Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma, ANTICANC R, 19(5C), 1999, pp. 4571-4576
Risultati: 1-15 |